MySafeRx™: An Integrated Mobile Platform for Buprenorphine Adherence

Completed · Not applicable

Conditions studied: Opioid Use Disorder

In brief

The goal of the MySafeRx study is to evaluate the feasibility, acceptability, and usability of a novel platform that integrates text messaging reminders, secure electronic pill organizers, and daily remote brief motivational recovery support visits with a standardized protocol for supervised self- administration of buprenorphine via videoconferencing.

Key facts

Study ID
NCT02778282
Run by
Dartmouth-Hitchcock Medical Center
People needed
27
Starts
2017-03-24
Expected to finish
2021-08-31
Last updated by the study team
2021-10-05

Who can join

Age: 18 and older, up to 39. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.